Allen J
Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Centre for Trauma and Mental Health Research, Vancouver Island University, Nanaimo, BC, Canada; School of Medical Sciences, Faculty of Health, University of Victoria, Victoria, BC, Canada.
ArticlePsilocybin
Psilocybin restores behavior and 5-HT<sub>2A</sub> signaling while reducing microglial density after chronic traumatic brain injury in rats.
PreprintPsilocybin
Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats
ArticlePsilocybin
Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.
ArticlePsilocybin
Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.
ArticlePsilocybin
Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?
ArticleKetamine